Cdk pathway: Cyclin-dependent kinases and cyclin-dependent kinase inhibitors

被引:0
|
作者
Diana M. Gitig
Andrew Koff
机构
[1] Room RRL 917a,
[2] Sloan-Kettering Institute,undefined
来源
Molecular Biotechnology | 2001年 / 19卷
关键词
Cyclin; cdk (cyclin dependent kinase); cki (cyclin dependent kinase inhibitor); FACS (fluorescent activated cell sorting); kinase assay; immunoblot (Western blot); coimmunoprecipitation;
D O I
暂无
中图分类号
学科分类号
摘要
Many mechanisms either activate or inhibit the cdks and thereby either promote or arrest progression through the mitotic cell cycle. Since the signal transduction pathways emanating from extracellular mitogens and the agents controlling these pathways are complicated there may yet be novel mechanisms of cell cycle regulation remaining to be elucidated. In this article we outline the different techniques used to study the cell cycle and its regulation. These include: establishing that the cell cycle is arrested by propidium iodide staining followed by FACS analysis or by measuring 3H-thymidine incorporation into DNA; measuring the amount of cyclin/cdk associated kinase activity; assessing the steady-state expression profiles of cyclins, cdks and ckis by immunoblotting; and investigating the formation of complexes between these proteins by coimmunoprecipitations. Caveats and advantages of each technique are discussed. Following this paradigm yielded the discovery of the cell cycle inhibitors p27Kip1 and p21Cip1 and could very well lead to the discovery or novel cell cycle regulatory mechanisms.
引用
收藏
页码:179 / 188
页数:9
相关论文
共 50 条
  • [21] Novel cyclin-dependent kinase inhibitors
    Westwell, AD
    DRUG DISCOVERY TODAY, 2001, 6 (13) : 701 - 701
  • [22] INHIBITORS OF CYCLIN-DEPENDENT KINASE AND CANCER
    BIGGS, JR
    KRAFT, AS
    JOURNAL OF MOLECULAR MEDICINE-JMM, 1995, 73 (10): : 509 - 514
  • [23] Cyclin-dependent kinase inhibitors and hepatocarcinogenesis
    Hui, AM
    Sakamoto, M
    Kanai, Y
    Ino, Y
    Gotoh, M
    Hirohashi, S
    RECENT ADVANCES IN GASTROENTEROLOGICAL CARCINOGENESIS I, 1996, : 481 - 485
  • [24] Cyclin-dependent kinases and CDK inhibitors in virus-associated cancers
    Tavakolian, Shaian
    Goudarzi, Hossein
    Faghihloo, Ebrahim
    INFECTIOUS AGENTS AND CANCER, 2020, 15 (01)
  • [25] Cyclin-dependent kinases and CDK inhibitors in virus-associated cancers
    Shaian Tavakolian
    Hossein Goudarzi
    Ebrahim Faghihloo
    Infectious Agents and Cancer, 15
  • [26] Characterization of novel inhibitors of cyclin-dependent kinases
    Kent, LL
    Hull-Campbell, NE
    Lau, T
    Wu, JC
    Thompson, SA
    Nori, M
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1999, 260 (03) : 768 - 774
  • [27] Identification of inhibitors of cyclin-dependent kinases.
    Veal, JM
    Bramson, N
    Dickerson, S
    Frye, S
    Harris, P
    Hassell, A
    Holmes, B
    Hunter, R
    Kuyper, L
    Lackey, K
    Lovejoy, B
    Luzzio, M
    Montana, V
    Rocque, W
    Shewchuk, L
    Walker, D
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1999, 218 : U1021 - U1022
  • [28] Novel arylazopyrazole inhibitors of cyclin-dependent kinases
    Jorda, Radek
    Schuetznerova, Eva
    Cankar, Petr
    Brychtova, Veronika
    Navratilova, Jana
    Krystof, Vladimir
    BIOORGANIC & MEDICINAL CHEMISTRY, 2015, 23 (09) : 1975 - 1981
  • [29] Inhibitors of cellular cyclin-dependent kinases as antivirals
    Schang, LM
    Bantly, A
    Rosenberg, A
    Schaffer, PA
    ANTIVIRAL RESEARCH, 2000, 46 (01) : A73 - A73
  • [30] Inhibitors of cyclin-dependent kinases as cancer therapeutics
    Whittaker, Steven R.
    Mallinger, Aurelie
    Workman, Paul
    Clarke, Paul A.
    PHARMACOLOGY & THERAPEUTICS, 2017, 173 : 83 - 105